Wilson Sonsini represented YS Biopharma on the deal. YishengBio Co., Ltd (YS Biopharma), a commercialization-stage biopharmaceutical company focusing on innovative vaccines and therapeutic biologics, and Summit...
Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.
Nano Labs’ Initial Public Offering
Hogan Lovells acted as the U.S. legal counsel to AMTD Global Markets Limited, Maxim Group LLC and Tiger Brokers (NZ) Limited. Wilson Sonsini Goodrich & Rosati...
BitFuFu’s Business Combination with Arisz Acquisition
Wilson Sonsini Goodrich & Rosati advised BitFuFu on the deal. FinFront Holding Company (BitFuFu), a fast-growing digital asset mining service and world-leading cloud-mining service provider, and...
Helens’ US$342 Million IPO and Listing on the HKSE
Wilson Sonsini Goodrich & Rosati advised Helens International Holdings Company Limited on the deal, while Davis Polk advised the underwriter. Helens International Holdings Company Limited (Helens)...
First High-School Education Group’s US$75 Million IPO
Wilson Sonsini Goodrich & Rosati and Maples and Calder advised First High-School Education Group Co. on the deal. Kirkland & Ellis International LLP acted as US...